trending Market Intelligence /marketintelligence/en/news-insights/trending/IdPL9HRMh4TYTsgZye-iag2 content esgSubNav
In This List

CytoSorbents chief medical officer retires; replacement named

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


CytoSorbents chief medical officer retires; replacement named

Cytosorbents Corp. said its chief medical officer Robert Bartlett has retired from his post, but will stay with the company as a consultant and as co-chair of the cardiac surgery advisory board.

Eric Mortensen, who was previously vice president and therapeutic area clinical head for inflammation and immunology at Pfizer Inc., will replace Bartlett as chief medical officer.